Cerebral, a telehealth startup focused on mental health, is cutting 20% of its staff, impacting “all divisions”; Cerebral was valued at $4.8B in December 2021
Context & Ripple Effects
Ten months ago Cerebral was one of the fastest-rising names in consumer mental health: a $127M round at a $1.23B valuation in June 2021 was followed within six months by a $300M raise at $4.8B led by Vision Fund 2. The same coverage window also flagged internal strain, with Forbes reporting some staff health insurance made contingent on quotas.
The cut lands in a sector already retrenching: meditation app Calm executed a 20% layoff of roughly 90 people in August 2022 despite its own $2B valuation. Cerebral's reduction across all divisions extends that pattern from wellness apps into prescription-backed telehealth.
First-order effects
- Roughly one in five Cerebral employees across every division loses their job, the first major contraction since the company's December 2021 peak-valuation fundraise.
- Vision Fund 2 and Access Industries, Cerebral's lead investors, now hold stakes in a company shrinking headcount less than a year after its top-of-market valuation.
Second-order effects
- Rival app-based mental health providers face the same post-2021 funding math and pressure to match cost cuts or justify their burn to their own backers.
- Patients relying on Cerebral for counseling and medication management risk service disruption as divisions lose staff simultaneously rather than sequentially.
Third-order effects
- If the Calm and Cerebral cuts mark a sector-wide reset, consumer mental health consolidates around companies that can reach profitability without new capital, ending the growth-at-all-costs hiring model of the 2021 funding cycle.
The trend: Consumer mental health startups funded at 2021 peak valuations are entering a synchronized retrenchment phase, with double-digit layoffs becoming the sector norm.